Signature Wealth Management Partners’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-3,454
Closed -$239K 96
2023
Q2
$239K Sell
3,454
-520
-13% -$37K 0.22% 85
2023
Q1
$295K Buy
3,974
+561
+16% +$47K 0.27% 77
2022
Q4
$318K Hold
3,413
0.31% 72
2022
Q3
$325K Sell
3,413
-30
-0.9% -$2.97K 0.36% 67
2022
Q2
$319K Sell
3,443
-100
-3% -$9.76K 0.33% 72
2022
Q1
$359K Hold
3,543
0.31% 74
2021
Q4
$365K Sell
3,543
-150
-4% -$13.9K 0.31% 72
2021
Q3
$313K Buy
3,693
+300
+9% +$25.1K 0.28% 76
2021
Q2
$283K Hold
3,393
0.26% 83
2021
Q1
$255K Hold
3,393
0.24% 84
2020
Q4
$232K Buy
+3,393
New +$221K 0.23% 84

Other funds holding CVS

Signature Wealth Management Partners's CVS Position: Q3 2023 in Review

Signature Wealth Management Partners sold out of CVS Health (CVS) in Q3 2023, closing a stake of 3,454 shares — an estimated $239K sold.

Signature Wealth Management Partners first reported a position in CVS in Q4 2020 and held it in 11 quarters. The position peaked at $365K in Q4 2021. 2,114 funds tracked by Wall St. Rank hold CVS as of Q3 2023.

  • Signature Wealth Management Partners reported no remaining CVS Health position as of Q3 2023 after selling out during the quarter.
  • Signature Wealth Management Partners sold 3,454 CVS Health shares in Q3 2023, an estimated $239K.
  • Signature Wealth Management Partners first reported a position in CVS Health in Q4 2020 and held it in 11 quarters.
  • Signature Wealth Management Partners's CVS Health position peaked at $365K in Q4 2021.
  • 2,114 funds tracked by Wall St. Rank held CVS Health as of Q3 2023.

Based on Signature Wealth Management Partners's 13F filing for Q3 2023, filed 24 Oct 2023.